Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer

被引:0
作者
Thomas K. Hamilton
Nianping Hu
Klodiana Kolomitro
Erin N. Bell
Donald H. Maurice
Charles H. Graham
D. Robert Siemens
机构
[1] Queen’s University,Department of Anatomy and Cell Biology
[2] Queen’s University,Department of Pharmacology and Toxicology
[3] Queen’s University,Department of Urology, Kingston General Hospital
来源
World Journal of Urology | 2013年 / 31卷
关键词
Phosphodiesterases; Phosphodiesterase inhibitors; Drug resistance; Immunotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:325 / 330
页数:5
相关论文
共 84 条
[1]  
Semenza GL(2002)HIF-1 and tumor progression: pathophysiology and therapeutics Trends Mol Med 8 S62-S67
[2]  
Movsas B(2000)Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: and Eppendorf pO(2) study Cancer 89 2018-2024
[3]  
Chapman JD(2010)Multi-drug resistance in cancer Methods Mol Biol 596 47-76
[4]  
Greenberg RE(2003)Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate J Urol 170 1003-1007
[5]  
Gillet J-P(2001)Nitric oxide-mediated regulation of chemosensitivity in cancer cells J Natl Cancer Inst 93 1879-1885
[6]  
Gottesmon MM(2005)Regulation of the multidrug resistance transporter P-glycoprotein in multicellular prostate tumor spheroids by hyperthermia and reactive oxygen species Int J Cancer 113 229-240
[7]  
Frederiksen LJ(2008)Hypoxia increases tumor cell shedding of MHC class I chain-related molecule: role of nitric oxide Cancer Res 68 4746-4753
[8]  
Siemens DR(2011)A mechanism of hypoxia-induced immune escape in cancer cells Cancer Res 71 7433-7441
[9]  
Heaton JP(2002)Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation Nature 419 734-738
[10]  
Matthews NE(2007)Chemosensitization of cancer in vitro and in vivo by nitric oxide signaling Clin Cancer Res 13 2199-2206